BOOK A CONSULTATION(opens in a new tab) Frequently Asked Questions How much weight can I expect to lose with GLP-1 medications
Preclinical studies demonstrated that tirzepatide reduced glucose levels during intraperitoneal glucose tolerance tests in wild-type and single incretin receptor-deficient mice to levels comparable to those observed for the GLP-1R agonist semaglutide in Gipr / mice and the DPP-4-resistant analog [d-Ala 2 ]GIP in Glp1r / mice, indicating that the co-agonist is active at both receptors in vivo [84]
The main mechanisms by which GLP1RAs promote tumor apoptosis encompass the cAMPPKAdependent pathway, the BMP4/Smad signaling pathway, the PI3K/Akt/mTOR signaling pathway, and the NF-B signaling pathway
The delayed gastric emptying caused by semaglutide can reduce absorption of oral contraceptives, potentially reducing their effectiveness
GLP-1 drugs are effective because they delay the stomach from emptying, creating a feeling of fullness, thereby having an increased effect on weight loss
Recognize Progress Beyond the Scale The number on the scale doesnt tell the whole story
